152 related articles for article (PubMed ID: 1727374)
1. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain.
Cornford EM; Young D; Paxton JW; Finlay GJ; Wilson WR; Pardridge WM
Cancer Res; 1992 Jan; 52(1):138-43. PubMed ID: 1727374
[TBL] [Abstract][Full Text] [Related]
2. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma.
Groothuis DR; Lippitz BE; Fekete I; Schlageter KE; Molnar P; Colvin OM; Roe CR; Bigner DD; Friedman HS
Cancer Res; 1992 Oct; 52(20):5590-6. PubMed ID: 1394182
[TBL] [Abstract][Full Text] [Related]
3. Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system.
Greig NH; Momma S; Sweeney DJ; Smith QR; Rapoport SI
Cancer Res; 1987 Mar; 47(6):1571-6. PubMed ID: 3815357
[TBL] [Abstract][Full Text] [Related]
4. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
Reichel A; Begley DJ; Abbott NJ
J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
[TBL] [Abstract][Full Text] [Related]
5. Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier.
Takada Y; Vistica DT; Greig NH; Purdon D; Rapoport SI; Smith QR
Cancer Res; 1992 Apr; 52(8):2191-6. PubMed ID: 1559223
[TBL] [Abstract][Full Text] [Related]
6. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+.
O'Kane RL; Viña JR; Simpson I; Zaragozá R; Mokashi A; Hawkins RA
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E412-9. PubMed ID: 16569760
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of transport of D-melphalan analogue by conjugation with L-glutamate across bovine brain microvessel endothelial cell monolayers.
Sakaeda T; Siahaan TJ; Audus KL; Stella VJ
J Drug Target; 2000; 8(3):195-204. PubMed ID: 10938529
[TBL] [Abstract][Full Text] [Related]
8. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
9. Neutral amino acid transport at the human blood-brain barrier.
Pardridge WM; Choi TB
Fed Proc; 1986 Jun; 45(7):2073-8. PubMed ID: 3519291
[TBL] [Abstract][Full Text] [Related]
10. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
11. "Facilitated" amino acid transport is upregulated in brain tumors.
Miyagawa T; Oku T; Uehara H; Desai R; Beattie B; Tjuvajev J; Blasberg R
J Cereb Blood Flow Metab; 1998 May; 18(5):500-9. PubMed ID: 9591842
[TBL] [Abstract][Full Text] [Related]
12. Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.
Takada Y; Greig NH; Vistica DT; Rapoport SI; Smith QR
Cancer Chemother Pharmacol; 1991; 29(2):89-94. PubMed ID: 1760863
[TBL] [Abstract][Full Text] [Related]
13. Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier.
O'Kane RL; Hawkins RA
Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1167-73. PubMed ID: 12933350
[TBL] [Abstract][Full Text] [Related]
14. Changes in the blood-brain transfer of L-phenylalanine elicited by arginine vasopressin.
Ermisch A; Reichel A; Brust P
Endocr Regul; 1992 Mar; 26(1):11-6. PubMed ID: 1421202
[TBL] [Abstract][Full Text] [Related]
15. Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
Peura L; Malmioja K; Laine K; Leppänen J; Gynther M; Isotalo A; Rautio J
Mol Pharm; 2011 Oct; 8(5):1857-66. PubMed ID: 21770378
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
17. Large neutral amino acid transporter enables brain drug delivery via prodrugs.
Gynther M; Laine K; Ropponen J; Leppänen J; Mannila A; Nevalainen T; Savolainen J; Järvinen T; Rautio J
J Med Chem; 2008 Feb; 51(4):932-6. PubMed ID: 18217702
[TBL] [Abstract][Full Text] [Related]
18. GAT2/BGT-1 as a system responsible for the transport of gamma-aminobutyric acid at the mouse blood-brain barrier.
Takanaga H; Ohtsuki S; Hosoya Ki ; Terasaki T
J Cereb Blood Flow Metab; 2001 Oct; 21(10):1232-9. PubMed ID: 11598501
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier transport of L-tyrosine Conjugates: a model study for the brain targeting using large neutral amino acid transport system.
Ohnishi T; Maruyama T; Higashi S; Awazu S
J Drug Target; 2000; 8(6):395-401. PubMed ID: 11328665
[TBL] [Abstract][Full Text] [Related]
20. Glial induction of blood-brain barrier-like L-system amino acid transport in the ECV304 cell line.
Chishty M; Reichel A; Begley DJ; Abbott NJ
Glia; 2002 Aug; 39(2):99-104. PubMed ID: 12112361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
